Cite
HARVARD Citation
Roesch, C. et al. (2020). Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia. Journal of antimicrobial chemotherapy. pp. 1766-1771. [Online].